FSCN1 and posterior cortical atrophy: Neuroendocrine prostate cancer (NEPC), a high-grade subtype of PCa, exclusively exhibits FSCN1 expression (Turpin et al., 2023), underlining its association with increased invasiveness, metastasis, and decreased patient survival rates (Darnel et al., 2009; Zhang et al., 2023).